Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Epstein-Barr virus: Biology and clinical disease

Cell(2022)10.1016/j.cell.2022.08.026Source: DataRank Database

Epstein-Barr virus: Biology and clinical disease is a research paper published in Cell (2022). On theSindex it has a DataRank of 0. It has been cited 577 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access577 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 41.56)OA: greenTopics (20)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Shannon C. Kenney ORCID,Nancy Raab‐Traub ORCID,Blossom Damania ORCID

Live enrichment

PubMed:36113467 OpenAlex:https://openalex.org/W4295921243

National Institutes of Health

Grant: AI147060

National Institutes of Health

Grant: CA019014

National Institutes of Health

Grant: CA022443

National Institutes of Health

Grant: CA163217

National Institutes of Health

Grant: CA228172

National Institutes of Health

Grant: CA229673

National Institutes of Health

Grant: CA232616

National Institutes of Health

Grant: CA239583

National Institutes of Health

Grant: DE028211

FWCI

41.56

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9529843

publisherhttps://api.elsevier.com/content/article/PII:S0092867422011217?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867422011217?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2022.08.026

Fields of Study

Viral-associated cancers and disordersLymphoma Diagnosis and TreatmentEosinophilic Disorders and Syndromes

MeSH Terms

BiologyHerpesvirus 4, HumanHumansRNAViral ProteinsVirus LatencyEpstein-Barr Virus Infections

Keywords

BiologyVirusEpstein–Barr virusImmune systemVirologyDiseaseViral life cycleImmunologyPopulationViral replication

Sustainable Development Goals

SDG 0: Zero hungerSDG 0: Responsible consumption and production

Related Papers (2)

Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus

Science Translational Medicine(2025)

co-cited

10.1126/scitranslmed.ady0210

Population-scale sequencing resolves determinants of persistent EBV DNA

N/A

0.411DataRank · unranked

Nature(2026)

co-cited

10.1038/s41586-025-10020-2